Schering Gains HCV Retreatment Indication For Pegintron/Rebetol In EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Commission clears the combination to retreat adults whose prior treatment with interferon alpha and ribavirin did not result in a sustained response.